Universe Pharmaceuticals INC 

$4.57
47
-$0.33-6.73% 11:31 Today

Statistics

Day High
4.5
Day Low
4.44
52W High
17.96
52W Low
2
Volume
1,299
Avg. Volume
-
Mkt Cap
2.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
May 4
$13.34
Feb 4
$13.34
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

16AugExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q2 2021
Q4 2021
Q2 2022
0
0.2
0.4
0.6
Expected EPS
0
Actual EPS
0.08

Financials

-20.56%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
17.86MRevenue
-3.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow UPC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap36.95M
111, Inc. operates in the Chinese health and wellness market, offering a similar range of pharmaceutical products and health services, directly competing with Universe Pharmaceuticals' market.
Zai Lab Limited
ZLAB
Mkt Cap2.31B
Zai Lab Limited is a biopharmaceutical company focusing on developing and commercializing medicines in oncology, autoimmune, and infectious diseases, areas that Universe Pharmaceuticals may also target.
HUTCHMED (China) Limited
HCM
Mkt Cap1.9B
Hutchison China MediTech Limited engages in the discovery, development, and commercialization of therapeutics and pharmaceutical products in China, directly competing in Universe Pharmaceuticals' market.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases, including diseases Universe Pharmaceuticals might target.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline plc is a global healthcare company that researches and develops a broad range of innovative medicines and brands, competing across several of Universe Pharmaceuticals' therapeutic areas.
Novartis
NVS
Mkt Cap293.94B
Novartis AG is a multinational pharmaceutical company that offers a wide range of healthcare products across various therapeutic areas, competing on a global scale, including the Chinese market.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. is one of the world's largest pharmaceutical companies, offering products that compete across the broad spectrum of medical needs covered by Universe Pharmaceuticals.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a global healthcare company that offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, competing in various therapeutic areas with Universe Pharmaceuticals.

About

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Show more...
CEO
Mr. Gang Lai
Employees
216
Country
Cayman Islands
ISIN
KYG9442G1385

Listings

1 Comments

FAQ

What is Universe Pharmaceuticals INC stock price today?
The current price of UPC is $4.57 USD — it has decreased by -6.73% in the past 24 hours. Watch Universe Pharmaceuticals INC stock price performance more closely on the chart.
What is Universe Pharmaceuticals INC stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Universe Pharmaceuticals INC stocks are traded under the ticker UPC.
Is Universe Pharmaceuticals INC stock price growing?
UPC stock has fallen by -13.66% compared to the previous week, the month change is a +56.36% rise, over the last year Universe Pharmaceuticals INC has showed a +28.17% increase.
What is Universe Pharmaceuticals INC market cap?
Today Universe Pharmaceuticals INC has the market capitalization of 2.95M
What were Universe Pharmaceuticals INC earnings last quarter?
UPC earnings for the last quarter are 0.08 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Universe Pharmaceuticals INC revenue for the last year?
Universe Pharmaceuticals INC revenue for the last year amounts to 17.86M USD.
What is Universe Pharmaceuticals INC net income for the last year?
UPC net income for the last year is -3.67M USD.
Does Universe Pharmaceuticals INC pay dividends?
Yes, UPC dividends are paid en. The last dividend per share was 13.34 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Universe Pharmaceuticals INC have?
As of July 17, 2026, the company has 216 employees.
In which sector is Universe Pharmaceuticals INC located?
Universe Pharmaceuticals INC operates in the Health & Wellness sector.
When did Universe Pharmaceuticals INC complete a stock split?
The last stock split for Universe Pharmaceuticals INC was on March 24, 2025 with a ratio of 1:40.
Where is Universe Pharmaceuticals INC headquartered?
Universe Pharmaceuticals INC is headquartered in Ji'An, Cayman Islands.